Gastrointestinal Diseases  >>  pioglitazone  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT01489943: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects

Completed
1
24
US
GSK1605786 500 mg, Midazolam 3 mg, Pioglitazone 15 mg, Omeprazole 40 mg, Rosuvastatin 10 mg
GlaxoSmithKline
Crohn's Disease
11/11
11/11
NCT01431521: Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)

Completed
1
31
NA
MK-4074 200 mg, Placebo for MK-4074, Pioglitazone hydrochloride 30 mg, Placebo for pioglitazone hydrochloride
Merck Sharp & Dohme LLC
Non-alcoholic Fatty Liver Disease
09/12
10/12

Download Options